Home → Tests → Triglycerides Test

Triglycerides Test

⚠️ Update approaching🔬 Evidence: StrongCardiology
Diğer adları: Blood fat test, TG, Trigs
⚠️

Discuss your test results with your doctor. This page is for informational purposes only and does not provide a diagnosis.

⚡ Key Facts

• A type of fat involved in energy transport in the blood • Elevated levels are associated with increased cardiovascular risk • Very high levels (>500 mg/dL) carry pancreatitis risk • Most affected by recent meals among lipid parameters

🧪 What Does This Test Measure?

The triglycerides test measures the level of triglycerides in the blood — fats obtained from food and produced by the liver, transported via VLDL and chylomicron particles.

📋 Why Is It Ordered?

Ordered as part of the lipid panel for cardiovascular risk assessment, metabolic syndrome evaluation, and pancreatitis risk assessment when levels are very high.

🔧 Preparation

Triglycerides are the lipid parameter most affected by recent meals. Guidelines accept non-fasting panels in most situations, but fasting may be preferred when triglyceride assessment is the primary focus.

📊 Reference Ranges

Fasting triglyceride classification: Normal: <150 mg/dL (<1.7 mmol/L) Borderline high: 150–199 mg/dL High: 200–499 mg/dL Very high: ≥500 mg/dL (pancreatitis risk) ⚠️ Reference ranges may vary by laboratory.

⬆️ High Values

Elevated triglycerides may be associated with dietary habits, alcohol consumption, obesity, diabetes, hypothyroidism, certain medications, and genetic conditions.

⬇️ Low Values

Low triglycerides are generally considered favorable. Very low levels rarely cause clinical concern; however, malnutrition, malabsorption, or hyperthyroidism may occasionally be associated.

⚙️ What Can Affect Results?

Diet, alcohol, body weight, physical activity, diabetes control, certain medications, and fasting status may affect triglyceride levels.

🔬 Evidence Summary

Strong evidence: 5 guidelines, 1 meta-analysis, 2 consensus/review studies.

📚 Most Important Studies on This Topic

1

Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society

Review· European Heart Journal · 2021 · PMID: 34472586

2

2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia

Guideline· Circulation · 2026 · PMID: 41824590

3

Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline

Guideline· Journal of Clinical Endocrinology & Metabolism · 2012 · PMID: 22962670

✅ Key Takeaways

💡

What you learned: Normal fasting triglycerides are below 150 mg/dL. Elevated levels are associated with cardiovascular risk, and very high levels may increase pancreatitis risk.

⛔

A triglyceride result alone cannot determine cardiovascular risk. The full lipid panel and clinical context are needed.

🔬 Sources Used on This Page

8 sources · Most recent publication: 2026
📋
Guideline
Expert society and guideline recommendations
5
sources
📊
Systematic review / meta-analysis
Combined analysis of multiple studies
1
source
📖
Review
Comprehensive topic evaluation
2
sources
Overall assessment: Evidence level for this topic is strong. This page is supported by 5 guidelines, 1 systematic review/meta-analysis, 2 reviews.

📝 Questions to Ask Your Doctor

Be prepared for your appointment. Add questions to your list.

📋 References

[PMID: 41824590] 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia. Circulation, 2026.
[PMID: 40878289] 2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias. European Heart Journal, 2025.
[PMID: 34472586] Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies—a consensus statement from the European Atherosclerosis Society. European Heart Journal, 2021.
[PMID: 31504418] 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. European Heart Journal, 2019.
[PMID: 30586774] 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. Circulation, 2018.
[PMID: 28444290] Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. European Heart Journal, 2017.
[PMID: 22962670] Evaluation and Treatment of Hypertriglyceridemia: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism, 2012.
[PMID: 22607825] Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. The Lancet, 2012.
Last reviewed: 3/31/2026
Next review: 3/31/2027

🔗 Related Topics

🩺 Metabolik sendrom🧪 LDL cholesterol🧪 HDL kolesterol🧪 Total kolesterol🧪 Açlık kan şekeri (metabolik sendrom bağlamı)
⚖️ This page does not replace medical advice. Make treatment decisions with your doctor.
Content is based on scientific studies indexed in PubMed and current clinical guidelines.